EUROPEAN BIOTECH ACQUTN CORP's ticker is EBACU and the CUSIP is G3167F110. A total of 38 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $317,000 | +1.3% | 32,046 | 0.0% | 0.02% | +5.9% |
| Q2 2022 | $313,000 | -0.6% | 32,046 | 0.0% | 0.02% | +6.2% |
| Q1 2022 | $315,000 | -0.9% | 32,046 | 0.0% | 0.02% | 0.0% |
| Q4 2021 | $318,000 | 0.0% | 32,046 | 0.0% | 0.02% | -11.1% |
| Q3 2021 | $318,000 | -0.3% | 32,046 | 0.0% | 0.02% | 0.0% |
| Q2 2021 | $319,000 | -21.8% | 32,046 | -21.0% | 0.02% | -25.0% |
| Q1 2021 | $408,000 | – | 40,559 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |